Biological Rationale for Peripheral Blood Cell–Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer

Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–44. https://doi.org/10.1038/nature07205.

Article  CAS  PubMed  Google Scholar 

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74. https://doi.org/10.1016/j.cell.2011.02.013.

Article  CAS  PubMed  Google Scholar 

Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883–99. https://doi.org/10.1016/j.cell.2010.01.025.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability—an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010;11(3):220–8. https://doi.org/10.1038/nrm2858.

Article  CAS  PubMed  Google Scholar 

Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30(7):1073–81. https://doi.org/10.1093/carcin/bgp127.

Article  CAS  PubMed  Google Scholar 

Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39–51. https://doi.org/10.1016/j.cell.2010.03.014.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mougiakakos D, Choudhury A, Lladser A, Kiessling R, Johansson CC. Chapter 3 - Regulatory T cells in cancer. In: Vande Woude GF, Klein G, editors. Advances in Cancer Research. Academic Press; 2010. p. 57–117.

Google Scholar 

Hiam-Galvez KJ, Allen BM, Spitzer MH. Systemic immunity in cancer. Nat Rev Cancer. 2021;21(6):345–59. https://doi.org/10.1038/s41568-021-00347-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guner A, Kim HI. Biomarkers for evaluating the inflammation status in patients with cancer. J Gastric Cancer. 2019;19(3):254–77. https://doi.org/10.5230/jgc.2019.19.e29.

Article  PubMed  PubMed Central  Google Scholar 

Mezquita L, Auclin E, Ferrara R, Charrier M, Remon J, Planchard D, et al. Association of the lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancer. JAMA Oncol. 2018;4(3):351–7. https://doi.org/10.1001/jamaoncol.2017.4771.

Article  PubMed  PubMed Central  Google Scholar 

Kazandjian D, Gong Y, Keegan P, Pazdur R, Blumenthal GM. Prognostic value of the lung immune prognostic index for patients treated for metastatic non-small cell lung cancer. JAMA Oncol. 2019;5(10):1481–5. https://doi.org/10.1001/jamaoncol.2019.1747. This study validated the lung immune prognostic index in patients with pretreated aNSCLC by a pooled analysis of randomised controlled trials with immunotherapy.

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Li Y, Chen P, Xu W, Wu Y, Che G. Prognostic value of the pretreatment systemic immune-inflammation index (SII) in patients with non-small cell lung cancer: a meta-analysis. Ann Transl Med. 2019;7(18):433. https://doi.org/10.21037/atm.2019.08.116.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lim JU, Yeo CD, Kang HS, Park CK, Kim JS, Kim JW, et al. Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion. Sci Rep. 2019;9(1):4721. https://doi.org/10.1038/s41598-019-41289-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell. 2010;140(6):771–6. https://doi.org/10.1016/j.cell.2010.03.006.

Article  CAS  PubMed  Google Scholar 

Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783–801. https://doi.org/10.1016/j.cell.2006.02.015.

Article  CAS  PubMed  Google Scholar 

Yano S, Nokihara H, Yamamoto A, Goto H, Ogawa H, Kanematsu T, et al. Multifunctional interleukin-1beta promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion- and angiogenesis-related molecules. Cancer Sci. 2003;94(3):244–52. https://doi.org/10.1111/j.1349-7006.2003.tb01428.x.

Article  CAS  PubMed  Google Scholar 

Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27–41. https://doi.org/10.1016/j.immuni.2019.06.025.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348(6230):74–80. https://doi.org/10.1126/science.aaa6204.

Article  CAS  PubMed  Google Scholar 

Jin MZ, Jin WL. The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther. 2020;5(1):166. https://doi.org/10.1038/s41392-020-00280-x.

Article  PubMed  PubMed Central  Google Scholar 

Bunt SK, Sinha P, Clements VK, Leips J, Ostrand-Rosenberg S. Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J Immunol. 2006;176(1):284–90. https://doi.org/10.4049/jimmunol.176.1.284.

Article  CAS  PubMed  Google Scholar 

Chen L, Huang CF, Li YC, Deng WW, Mao L, Wu L, et al. Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma. Cell Mol Life Sci. 2018;75(11):2045–58. https://doi.org/10.1007/s00018-017-2720-9.

Article  CAS  PubMed  Google Scholar 

Chaudhry SI, Hooper S, Nye E, Williamson P, Harrington K, Sahai E. Autocrine IL-1beta-TRAF6 signalling promotes squamous cell carcinoma invasion through paracrine TNFalpha signalling to carcinoma-associated fibroblasts. Oncogene. 2013;32(6):747–58. https://doi.org/10.1038/onc.2012.91.

Article  CAS  PubMed  Google Scholar 

Taniguchi K, Karin M. NF-kappaB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18(5):309–24. https://doi.org/10.1038/nri.2017.142.

Article  CAS  PubMed  Google Scholar 

Elaraj DM, Weinreich DM, Varghese S, Puhlmann M, Hewitt SM, Carroll NM, et al. The role of interleukin 1 in growth and metastasis of human cancer xenografts. Clin Cancer Res. 2006;12(4):1088–96. https://doi.org/10.1158/1078-0432.CCR-05-1603.

Article  CAS  PubMed  Google Scholar 

Kim JW, Koh Y, Kim DW, Ahn YO, Kim TM, Han SW, et al. Clinical Implications of VEGF, TGF-beta1, and IL-1beta in Patients with advanced non-small cell lung cancer. Cancer Res Treat. 2013;45(4):325–33. https://doi.org/10.4143/crt.2013.45.4.325.

Article  PubMed  PubMed Central  Google Scholar 

Millares L, Barreiro E, Cortes R, Martinez-Romero A, Balcells C, Cascante M, et al. Tumor-associated metabolic and inflammatory responses in early stage non-small cell lung cancer: local patterns and prognostic significance. Lung Cancer. 2018;122:124–30. https://doi.org/10.1016/j.lungcan.2018.06.015.

Article  PubMed  Google Scholar 

de Visser KE, Coussens LM. The inflammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol. 2006;13:118–37. https://doi.org/10.1159/000092969.

Article  PubMed  Google Scholar 

Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol. 2008;66(1):1–9. https://doi.org/10.1016/j.critrevonc.2007.07.004.

Article  PubMed  Google Scholar 

Balkwill FR, Capasso M, Hagemann T. The tumor microenvironment at a glance. J Cell Sci. 2012;125(Pt 23):5591–6. https://doi.org/10.1242/jcs.116392.

Article  CAS  PubMed  Google Scholar 

Jang JH, Kim DH, Surh YJ. Dynamic roles of inflammasomes in inflammatory tumor microenvironment. NPJ Precis Oncol. 2021;5(1):18. https://doi.org/10.1038/s41698-021-00154-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leach M. Interpretation of the full blood count in systemic disease—a guide for the physician. J R Coll Phys Edinb. 2014;44(1):36–41. https://doi.org/10.4997/JRCPE.2014.109.

Article  CAS  Google Scholar 

Velioglu Y, Yuksel A. Complete blood count parameters in peripheral arterial disease. Aging Male. 2019;22(3):187–91. https://doi.org/10.1080/13685538.2019.1588873.

Article  CAS  PubMed  Google Scholar 

Zinellu A, Paliogiannis P, Sotgiu E, Mellino S, Mangoni AA, Zinellu E, et al. Blood Cell count derived inflammation indexes in patients with idiopathic pulmonary fibrosis. Lung. 2020;198(5):821–7. https://doi.org/10.1007/s00408-020-00386-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88(1):218–30. https://doi.org/10.1016/j.critrevonc.2013.03.010.

Article  PubMed  Google Scholar 

Sacdalan DB, Lucero JA, Sacdalan DL. Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis. Onco Targets Ther. 2018;11:955–65. https://doi.org/10.2147/OTT.S153290.

Article  PubMed  PubMed Central 

留言 (0)

沒有登入
gif